Showing 1 - 20 results of 20 for search 'Mark Jit', query time: 0.03s
Refine Results
-
1
-
2
Global socioeconomic inequalities in vaccination coverage, supply, and confidence by Qiang Wang, Kathy Leung, Mark Jit, Joseph T. Wu, Leesa Lin
Published 2025-05-01Get full text
Article -
3
-
4
-
5
Cost-effectiveness analysis of switching from a bivalent to a nonavalent HPV vaccination programme in China: a modelling studyResearch in context by Meng Gao, Shangying Hu, Xuelian Zhao, Tingting You, Yuting Hong, Yang Liu, Youlin Qiao, Mark Jit, Fanghui Zhao, Chen Wang
Published 2025-03-01Get full text
Article -
6
-
7
-
8
Maternal immunisation against Group B Streptococcus: A global analysis of health impact and cost-effectiveness. by Simon R Procter, Bronner P Gonçalves, Proma Paul, Jaya Chandna, Farah Seedat, Artemis Koukounari, Raymond Hutubessy, Caroline Trotter, Joy E Lawn, Mark Jit
Published 2023-03-01Get full text
Article -
9
The global economic burden of antibiotic-resistant infections and the potential impact of bacterial vaccines: a modelling study by Mark Jit, Julie V Robotham, Isabel Frost, Kaja Abbas, Nichola R Naylor, Chaelin Kim, Mateusz Hasso-Agopsowicz, Yixuan Ma, Gisela Aguilar, Naomi Fuller
Published 2025-06-01Get full text
Article -
10
-
11
The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling study. by Allison Portnoy, Jean-Louis Arcand, Rebecca A Clark, Chathika K Weerasuriya, Christinah Mukandavire, Roel Bakker, Edith Patouillard, Nebiat Gebreselassie, Matteo Zignol, Mark Jit, Richard G White, Nicolas A Menzies
Published 2023-07-01Get full text
Article -
12
Comparing human and model-based forecasts of COVID-19 in Germany and Poland. by Nikos I Bosse, Sam Abbott, Johannes Bracher, Habakuk Hain, Billy J Quilty, Mark Jit, Centre for the Mathematical Modelling of Infectious Diseases COVID-19 Working Group, Edwin van Leeuwen, Anne Cori, Sebastian Funk
Published 2022-09-01Get full text
Article -
13
Influential drivers of the cost-effectiveness of respiratory syncytial virus vaccination in European older adults: a multi-country analysis by Xiao Li, Lander Willem, Caroline Klint Johannesen, Arantxa Urchueguía-Fornes, Toni Lehtonen, Richard Osei-Yeboah, Heini Salo, Alejandro Orrico-Sánchez, Javier Díez-Domingo, Mark Jit, for PROMISE investigators, Joke Bilcke, Harish Nair, Philippe Beutels
Published 2025-03-01Get full text
Article -
14
Population-Wide Depression Incidence Forecasting Comparing Autoregressive Integrated Moving Average and Vector Autoregressive Integrated Moving Average to Temporal Fusion Transform... by Deliang Yang, Yiyi Tang, Vivien Kin Yi Chan, Qiwen Fang, Sandra Sau Man Chan, Hao Luo, Ian Chi Kei Wong, Huang-Tz Ou, Esther Wai Yin Chan, David Makram Bishai, Yingyao Chen, Martin Knapp, Mark Jit, Dawn Craig, Xue Li
Published 2025-05-01Get full text
Article -
15
The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study. by Allison Portnoy, Rebecca A Clark, Matthew Quaife, Chathika K Weerasuriya, Christinah Mukandavire, Roel Bakker, Arminder K Deol, Shelly Malhotra, Nebiat Gebreselassie, Matteo Zignol, So Yoon Sim, Raymond C W Hutubessy, Inés Garcia Baena, Nobuyuki Nishikiori, Mark Jit, Richard G White, Nicolas A Menzies
Published 2023-01-01Get full text
Article -
16
An Application of an Initial Full Value of Vaccine Assessment Methodology to Measles-Rubella MAPs for Use in Low- and Middle-Income Countries by Melissa Ko, Collrane Frivold, Mercy Mvundura, Adam Soble, Christopher Gregory, Hans Christiansen, Mateusz Hasso-Agopsowicz, Han Fu, Mark Jit, Shan Hsu, Jessica Joyce Mistilis, Tiziana Scarna, Kristen Earle, Marion Menozzi-Arnaud, Birgitte Giersing, Courtney Jarrahian, Ahmadu Yakubu, Stefano Malvolti, Jean-Pierre Amorij
Published 2024-09-01Get full text
Article -
17
The potential global health impact and cost-effectiveness of next-generation influenza vaccines: A modelling analysis. by Lucy Goodfellow, Simon R Procter, Mihaly Koltai, Naomi R Waterlow, Johnny A N Filipe, Carlos K H Wong, Edwin van Leeuwen, Rosalind M Eggo, Mark Jit, WHO Technical Advisory Group for the Full Value of Influenza Vaccines Assessment and project team, Next-generation influenza vaccine impact modelling contributors
Published 2025-06-01Get full text
Article -
18
Enhancing global health security responses through greater inclusion of the global south in infectious disease modelling by Mark Jit, Kiesha Prem, Yot Teerawattananon, Wanrudee Isaranuwatchai, Kathy Leung, Waranya Rattanavipapong, Saudamini Vishwanath Dabak, Wirichada Pan-Ngum, Jodie McVernon, Jarawee Sukmanee, Alex R. Cook, Joseph T. Wu, Pritaporn Kingkaew, Siuli Mukhopadhyay, Angkana Huang, Bimandra Djaafara, Thinh Ong Phuc, Saranyu Laemlak, Vera W. Chua
Published 2025-08-01Get full text
Article -
19
Effect of a pay-it-forward strategy on reducing HPV vaccine delay and increasing uptake among 15- to 18-year-old girls in China: A randomized controlled trial. by Jing Li, Yifan Li, Chuanyu Qin, Yu He, Haidong Lu, Yewei Xie, Jason J Ong, Yajiao Lu, Ying Yang, Fan Yang, Heng Du, Wenfeng Gong, Fei Zou, Heidi J Larson, Mark Jit, Leesa Lin, Jennifer S Smith, Elvin H Geng, Dong Xu, Weiming Tang, Shenglan Tang, Joseph D Tucker, Dan Wu
Published 2025-07-01Get full text
Article -
20
The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study. by Stefan Flasche, Mark Jit, Isabel Rodríguez-Barraquer, Laurent Coudeville, Mario Recker, Katia Koelle, George Milne, Thomas J Hladish, T Alex Perkins, Derek A T Cummings, Ilaria Dorigatti, Daniel J Laydon, Guido España, Joel Kelso, Ira Longini, Jose Lourenco, Carl A B Pearson, Robert C Reiner, Luis Mier-Y-Terán-Romero, Kirsten Vannice, Neil Ferguson
Published 2016-11-01Get full text
Article